Comparison of zafirlukast (Accolate®) absorption after oral and colonie administration in humans

Pharmaceutical Research

Volumn 17, Issue 2, 2000, Pages 154-159

  Fischer, Jeff D ^a,e   Song, Min H ^a   Suttle, A Benjamin ^b,f   Heizer, William D ^c   Burns, Charles B ^d   Vargo, Dennis L ^b   Brouwer, Kim L R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b ASTRAZENECA   (United Kingdom)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^e IQVIA   (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Absorption; Accolate ; And oroenteric; Colon; Zafirlukast

Indexed keywords

ZAFIRLUKAST;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIGITAL RADIOGRAPHY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; FLUOROSCOPY; GAMMA SCINTIGRAPHY; GASTROINTESTINAL ABSORPTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; ILEUM; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; ANTI-ASTHMATIC AGENTS; CATHETERIZATION; COLON; CROSS-OVER STUDIES; GAMMA CAMERAS; HUMANS; ILEUM; INTESTINAL ABSORPTION; INTUBATION, GASTROINTESTINAL; MALE; TOSYL COMPOUNDS;

EID: 0034019964     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007509112383     Document Type: Article

References (14)

1. 1. P. Jain and J. A. Golish. Clinical management of asthma in the 1990s. Current therapy and new directions. Drugs. 52 Supplement 6:1-11 (1996).
2. 2. S. L. Spector. Management of asthma with zafirlukast. Clinical experiences tolerability profile. Drugs. 52 Supplement 6:36-46 (1996).
3. 3. P. M. O'Byrne. Leukotrienes in the pathogenesis of asthma. Chest. 111 Supplement 2:27S-34S (1997).
4. 4. Zeneca Pharmaceuticals. Investigational drug brochure for Accolate™ (zafirlukast). 8th edition (1996).
5. 5. R. D. Savidge, K. H. Bui, B. K. Birmingham, J. L. Morse, and R. C. Spreen. Metabolism and excretion of zafirlukast in dogs, rats, and mice. Drug Metab. Dispos. 26:1069-1076 (1998).
6. 6. P. Kerlin, R. Tucker, and S. F. Phillips. Rapid intubation of the ileo-colonic region of man. Aust. N. Z. J. Med. 13:591 -593 (1983).
7. 7. M. F. Williams, G. E. Dukes, W. Heizer, Y. H. Han, D. J. Hermann, T. Lampkin, and L. J. Hak. Influence of gastrointestinal site of drug delivery on the absorption characteristics of ranitidine. Pharm. Res. 9:1190-1194 (1992).
8. 8. K. H. Bui, C. M. Kennedy, C. T. Azumaya, and B. K. Birmingham. Determination of zafirlukast, a selective leukotriene antagonist, in human plasma by normal-phase high performance liquid chromatography with fluorescence detection. J. Chrom. 696:131-136 (1997).
9. 9. P. H. Hsyu, J. F. Pritchard, H. P. Bozigian, T. L. Lloyd, R. H. Griffin, R. Shamburek, G. Krishna, and W. H. Barr. Comparison of the pharmacokinetics of an ondansetron solution (8 mg) when administered intravenously, orally, to the colon, and to the rectum. Pharm. Res. 11:156-159 (1994).
10. 10. K. K. Chan, A. Buch, R. D. Glazer, V. A. John, and W. H. Barr. Site-differential gastrointestinal absorption of benazepril hydrochloride in healthy volunteers. Pharm. Res. 11:432-437 (1994).
11. 11. W. H. Barr, E. M. Zola, E. L. Candler, S. M. Hwang, A. V. Tendolkar, R. Shamburek, B. Parker, and M. D. Hilty. Differential absorption of amoxicillin from the human small and large intestine. Clin Pharmacol. Ther. 56:279-285 (1994).
12. 12. K. K. Chan, P. Mojaverian, B. A. Ziehmer, and V. A. John. Application of radiotelemetric technique in evaluating diclofenac sodium absorption after oral administration of various dosage forms in healthy volunteers. Pharm. Res. 7:1026-1032 (1990).
13. 13. T. L. Russell, R. R. Berardi, J. L. Barnett, T. L. O'Sullivan, J. G. Wagner, and J. B. Dressman. pH-related changes in the absorption of dipyridamole in the elderly. Pharm. Res. 11:136-143 (1994).
14. 14. S. Mattioli, V. Felice, V. Pilotti, M. L. Bacchi, M. Pastina, and G. Gozzetti. Indications for 24-hour gastric pH monitoring with single and multiple probes in clinical research and practice. Dig. Dis. Sci. 37:1793-1801 (1992).